Feed Preview

MS: Therapies

MS: Therapies diagram by Molecular Sensei, Shutterstock
Molecular Sensei, Shutterstock

The feed focuses on therapeutic interventions used to treat Multiple Sclerosis.

Top 20 most recent papers
May 24, 2020
Review

Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?

Current Neurology and Neuroscience Reports
Magdalena OsetMariola Matysiak
May 23, 2020

Oligodendrocyte ARNT2 expression is altered in models of MS

Neurology. Neuroimmunology and Neuroinflammation
Pierre BecquartJacqueline A Quandt
May 23, 2020
Open Access

Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion

Advanced Science
Sander BekeschusAnke Schmidt
May 23, 2020

Improved Cervical Cord Lesion Detection with 3D-MP2RAGE Sequence in Patients with Multiple Sclerosis

AJNR. American Journal of Neuroradiology
S DemortièreV Callot
May 23, 2020

Effect of sildenafil on neuroinflammation and synaptic plasticity pathways in experimental autoimmune encephalomyelitis

International Immunopharmacology
Shyrlene Meiry da Rocha AraújoChristina Alves Peixoto
May 24, 2020
Review

Caregiver Burden in Multiple Sclerosis: Recent Trends and Future Directions

Current Neurology and Neuroscience Reports
Rebecca Maguire, Phil Maguire
May 24, 2020
Case Report

Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report

Multiple Sclerosis and Related Disorders
Muhannad A AlnahdiYaser M Al Malik
May 23, 2020

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy

BMC Neurology
Martin VališZbyšek Pavelek
May 24, 2020
ReviewOpen Access

Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies

Brain Sciences
Alexey Boyko, Mikhail Melnikov
May 22, 2020
Open Access

Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis

Journal of Neuroinflammation
Ana ZabalzaJose E Martínez-Rodríguez
May 23, 2020

Diagnostic features of initial demyelinating events associated with serum MOG-IgG

Journal of Neuroimmunology
Riccardo OrlandiAlberto Gajofatto
May 24, 2020
Case Report

A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis

Multiple Sclerosis and Related Disorders
Doruk ArslanMeryem Aslı Tuncer

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/ms-therapies/8225165c-32ef-48e6-8979-3ff53ccb5b03